The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Abbott; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Speakers' Bureau - Abbott; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Novartis; Pfizer; Roche
Health-related quality of life (HRQoL) in the KEYNOTE-189 study of pembrolizumab (pembro) or placebo (pbo) + pemetrexed (pem) + platinum (plt) for metastatic NSCLC.
 
Marina Chiara Garassino
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Roche
Speakers' Bureau - AstraZeneca
Research Funding - AstraZeneca (Inst); AstraZeneca (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly; MSD Oncology; Pfizer
Other Relationship - Roche/Genentech; Roche/Genentech
 
Delvys Rodriguez-Abreu
Consulting or Advisory Role - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
Speakers' Bureau - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
Travel, Accommodations, Expenses - Hoffmann-La Roche, Bristol-Myers Squibb, MSD, Boehringer- Ingelheim
 
Shirish M. Gadgeel
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; Pfizer
Speakers' Bureau - AstraZeneca
Research Funding - ACEA Biosciences (Inst); Acerta Pharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Genentech/Roche (Inst); Halozyme (Inst); Incyte (Inst); Janssen Oncology (Inst); Merck; Merck (Inst); Millennium (Inst); Novartis (Inst); OncoMed (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - ARIAD/Takeda; Genentech/Roche
 
Emilio Esteban González
No Relationships to Disclose
 
Enriqueta Felip
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Guardant Health; Lilly; MSD; Novartis; Pfizer; Roche; Takeda
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Pfizer; Roche
 
Flavia De Angelis
Consulting or Advisory Role - AstraZeneca; Merck
Travel, Accommodations, Expenses - Novartis
 
Manuel Domine
No Relationships to Disclose
 
Maximilian J. Hochmair
No Relationships to Disclose
 
Steven Francis Powell
Consulting or Advisory Role - Bristol-Myers Squibb (Inst)
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Incyte (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Pfizer (Inst); Vyriad (Inst)
 
Susanna Y. Cheng
Honoraria - Merck; Roche
Consulting or Advisory Role - Merck; Roche
 
Helge Bischoff
No Relationships to Disclose
 
Nir Peled
Consulting or Advisory Role - Advisor & Honorarium for AZ, BI, BMS, Lilly , MSD, Novartis, pfizer, Roche
Speakers' Bureau - Advisor & Honorarium for AZ, BI, BMS, Lilly , MSD, Novartis, pfizer, Roche
 
Martin Reck
No Relationships to Disclose
 
Rina Hui
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis
Consulting or Advisory Role - AstraZeneca; MSD; Novartis; Roche
Travel, Accommodations, Expenses - Roche
 
Edward B. Garon
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Lilly (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst)
 
Michael J. Boyer
Consulting or Advisory Role - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck Sharp & Dohme (Inst)
Research Funding - Amgen (Inst); Ascentage Pharma (Inst); AstraZeneca (Inst); BeiGene (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); OncoMed (Inst); Peregrine Pharmaceuticals (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Genentech/Roche; Merck Sharp & Dohme
 
Jing Yang
Employment - Merck
Stock and Other Ownership Interests - Merck
 
Thomas A. Burke
Employment - Merck
 
Maria Catherine Pietanza
Employment - Merck
Stock and Other Ownership Interests - Merck Sharp & Dohme
 
Leena Gandhi
Consulting or Advisory Role - AstraZeneca; Hengrui Pharmaceutical ; Ignyta; Merck Sharp & Dohme; Roche/Genentech; Syndax
Research Funding - Bristol-Myers Squibb